Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
19.51
+0.06 (0.31%)
Apr 29, 2026, 3:00 PM CST
SHA:688553 Revenue
Sichuan Huiyu Pharmaceutical had revenue of 269.21M CNY in the quarter ending March 31, 2026, with 12.61% growth. This brings the company's revenue in the last twelve months to 1.03B, down -5.73% year-over-year. In the year 2025, Sichuan Huiyu Pharmaceutical had annual revenue of 998.14M, down -8.79%.
Revenue (ttm)
1.03B
Revenue Growth
-5.73%
P/S Ratio
7.97
Revenue / Employee
n/a
Employees
1,331
Market Cap
8.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 998.14M | -96.24M | -8.79% |
| Dec 31, 2024 | 1.09B | 167.31M | 18.05% |
| Dec 31, 2023 | 927.08M | -566.19M | -37.92% |
| Dec 31, 2022 | 1.49B | -330.47M | -18.12% |
| Dec 31, 2021 | 1.82B | 459.54M | 33.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.50B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Shandong Lukang Pharmaceutical | 5.71B |
| Tianjin Ringpu Bio-Technology | 3.40B |
| Jiangsu Kanion Pharmaceutical | 3.29B |
| Jiuzhitang | 2.23B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Guilin Sanjin Pharmaceutical | 2.08B |